Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is comparing LY03020 with placebo for people with Schizophrenia or Alzheimer's Disease Psychosis. Participants receive LY03020 or placebo and complete study visits and assessments.
This observational study is following people with psychosis, Family Members, Anosognosia, or Paranoia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether Brexpiprazole long-acting injection can help people with Schizophrenia Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing MI-CBTech with Mindfulness control for people with psychosis. Participants receive MI-CBTech or Mindfulness control and complete study visits and assessments.
This study is looking at whether cognitive behavioural therapy can help people with Schizophrenia and Related Disorders or Sleep Disturbance. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at evaluate the long-term safety of NBI-1117568 in adults with schizophrenia. Taking part may give some people access to NBI-1117568, but direct benefit is not guaranteed.
This observational study is following people with Schizophrenia Spectrum Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at evaluate the efficacy and safety of cariprazine in the treatment of schizophrenia in the adolescent population. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at confirm this hypothesis using novel blood biomarkers and Positron Emission Tomography (PET) imaging tracers, as well as non-invasive testing for people with Late Onset Schizophrenia or Delusional Disorder. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether a digital support tool can help people with Schizophrenia and Related Disorders or Early Treatment-Resistance. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at investigate the effects of 4-week rTMS treatment on brain and cognitive functions in patients for people with Schizophrenia, Cerebellar Function, or Condition. Some participants may receive Sham instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with Schizophrenia and Related Disorders, Mitochondrial Alteration, or Cognitive Impairment to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Schizophrenia and Schizophrenia Spectrum Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Cognitive Impairment Associated With Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at examine changes in synaptic density with transcranial direct current stimulation (tDCS) in the brains of patients with schizophrenia for people with Schizophrenia or Schizoaffective. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing stg-rt-fMRI-Neurofeeback with sham-rt-fMRI for people with Schizophrenia, Auditory Hallucination, or Treatment-resistant Schizophrenia. Participants receive stg-rt-fMRI-Neurofeeback or sham-rt-fMRI and complete study visits and assessments.
This study is looking at examine the sex difference in the efficacy of an NMDA-enhancer (NMDAE) for the treatment of negative symptoms in schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Schizophrenia. Taking part may give some people access to BR5402A, but direct benefit is not guaranteed.
This study is looking at whether Pimavanserin can help people with Parkinson's Disease Psychosis or Dementia With Lewy Bodies. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at compare brain glutamate, glucose utilisation, lactate production and brain activity in healthy volunteers and people with a diagnosis of schizophrenia. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Schizophrenia Disorders. Taking part may give some people access to Brief Activities, but direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Schizophrenia. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.